Congressional researchers are giving an update on the status of the federal-state marijuana law conflict, detailing the limitations of a pending rescheduling action, laying out options for lawmakers to address the issue and noting changes to hemp policy that are set to take effect later this year.
Notably, the new report removes language from an earlier version that had said it is “likely” federal officials “will move marijuana from Schedule I to Schedule III.”
In an “In Focus” report from the Congressional Research Service (CRS), analysts explained how it’s “increasingly common for states to have laws and policies allowing for medical or recreational use of marijuana” that remains in violation of the federal Controlled Substances Act (CSA).
Federal agencies under the Biden administration recommended moving cannabis from Schedule I to Schedule III of the CSA following a scientific review—and President Donald Trump in December issued an executive order directing Attorney General Pam Bondi to quickly complete that process—but that hasn’t materialized yet.
If cannabis is reclassified, however, that “would not bring the state-legal medical marijuana industry into compliance with the CSA” without additional legal changes, CRS said. And while Congress has held hearings and introduced bills proposing a variety of
Read full article on Marijuana Moment
